As on Wednesday, SILO Pharma Inc (NASDAQ: SILO) started slowly as it slid -15.33% to $0.82, before settling in for the price of $0.97 at the close. Taking a more long-term approach, SILO posted a 52-week range of $0.77-$4.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -19.76%. Meanwhile, its Annual Earning per share during the time was -4.01%. This publicly-traded company’s shares outstanding now amounts to $4.48 million, simultaneously with a float of $4.29 million. The organization now has a market capitalization sitting at $3.68 million. At the time of writing, stock’s 50-day Moving Average stood at $1.0498, while the 200-day Moving Average is $1.4348.
SILO Pharma Inc (SILO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. SILO Pharma Inc’s current insider ownership accounts for 4.25%, in contrast to 7.53% institutional ownership. According to the most recent insider trade that took place on Dec 13 ’24, this organization’s CEO and President bought 2,500 shares at the rate of 0.84, making the entire transaction reach 2,097 in total value, affecting insider ownership by 187,932. Preceding that transaction, on Nov 20 ’24, Company’s CEO and President bought 2,500 for 0.95, making the whole transaction’s value amount to 2,375. This particular insider is now the holder of 182,932 in total.
SILO Pharma Inc (NASDAQ: SILO) Trading Performance Indicators
Let’s observe the current performance indicators for SILO Pharma Inc (SILO). It’s Quick Ratio in the last reported quarter now stands at 7.91. The Stock has managed to achieve an average true range (ATR) of 0.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 52.62.
In the same vein, SILO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.19.
Technical Analysis of SILO Pharma Inc (SILO)
Through scrutinizing the latest numbers posted by the [SILO Pharma Inc, SILO], it can be observed that its last 5-days Average volume of 0.31 million was lower the volume of 1.51 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 52.66% While, its Average True Range was 0.1117.
Raw Stochastic average of SILO Pharma Inc (SILO) in the period of the previous 100 days is set at 2.99%, which indicates a major fall in contrast to 14.53% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 113.57% that was higher than 95.31% volatility it exhibited in the past 100-days period.
